JP2006514940A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514940A5
JP2006514940A5 JP2004557232A JP2004557232A JP2006514940A5 JP 2006514940 A5 JP2006514940 A5 JP 2006514940A5 JP 2004557232 A JP2004557232 A JP 2004557232A JP 2004557232 A JP2004557232 A JP 2004557232A JP 2006514940 A5 JP2006514940 A5 JP 2006514940A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
methoxy
tert
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004557232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514940A (ja
JP4926402B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/037104 external-priority patent/WO2004050642A1/en
Publication of JP2006514940A publication Critical patent/JP2006514940A/ja
Publication of JP2006514940A5 publication Critical patent/JP2006514940A5/ja
Application granted granted Critical
Publication of JP4926402B2 publication Critical patent/JP4926402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004557232A 2002-11-27 2003-11-20 サイトカインインヒビターとしての1,2,3−トリアゾールアミド誘導体 Expired - Lifetime JP4926402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43051902P 2002-11-27 2002-11-27
US60/430,519 2002-11-27
PCT/US2003/037104 WO2004050642A1 (en) 2002-11-27 2003-11-20 1, 2, 3- triazole amide derivatives as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2006514940A JP2006514940A (ja) 2006-05-18
JP2006514940A5 true JP2006514940A5 (https=) 2007-01-18
JP4926402B2 JP4926402B2 (ja) 2012-05-09

Family

ID=32469486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004557232A Expired - Lifetime JP4926402B2 (ja) 2002-11-27 2003-11-20 サイトカインインヒビターとしての1,2,3−トリアゾールアミド誘導体

Country Status (9)

Country Link
US (2) US7166628B2 (https=)
EP (1) EP1567507B1 (https=)
JP (1) JP4926402B2 (https=)
AT (1) ATE329909T1 (https=)
AU (1) AU2003294388A1 (https=)
CA (1) CA2507184C (https=)
DE (1) DE60306193T2 (https=)
ES (1) ES2265596T3 (https=)
WO (1) WO2004050642A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
DE602004031759D1 (de) * 2003-12-03 2011-04-21 Boehringer Ingelheim Pharma 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion
US7485657B2 (en) * 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
US7803822B2 (en) 2005-04-06 2010-09-28 Takeda Pharmaceutical Company Limited Triazole derivative and use thereof
US20060258888A1 (en) * 2005-05-12 2006-11-16 Boehringer Ingelheim International, Gmbh Bis-Amination of Aryl Halides
ES2353724T3 (es) * 2005-07-25 2011-03-04 F. Hoffmann-La Roche Ag Derivados de triazol substitutidos y su uso como antagonistas del receptor neuroquinina 3.
PE20080401A1 (es) 2006-07-07 2008-06-23 Boehringer Ingelheim Int DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
PE20090837A1 (es) * 2007-07-02 2009-07-24 Boehringer Ingelheim Int Nuevos compuestos quimicos
US20100240657A1 (en) * 2007-07-02 2010-09-23 Boehringer Ingelheim International Gmbh Chemical compounds
TW201014860A (en) 2008-09-08 2010-04-16 Boehringer Ingelheim Int New chemical compounds
AR073700A1 (es) 2008-09-29 2010-11-24 Boehringer Ingelheim Int Heterociclos y composiciones farmaceuticas para usarse en el tratamiento de cancer, infecciones y enfermedades autoinmunitarias
JP5603883B2 (ja) 2009-02-17 2014-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング B−Rafキナーゼを阻害するためのピリミドピリミジン誘導体
JP2011057661A (ja) 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
WO2011117382A1 (en) 2010-03-26 2011-09-29 Boehringer Ingelheim International Gmbh Pyridyltriazoles
JP5871896B2 (ja) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング B−rafキナーゼインヒビター
US8710055B2 (en) 2010-12-21 2014-04-29 Boehringer Ingelheim International Gmbh Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
US8889684B2 (en) 2011-02-02 2014-11-18 Boehringer Ingelheim International Gmbh Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
CA2893239A1 (en) * 2012-12-03 2014-06-12 F. Hoffmann-La Roche Ag Substituted triazole and imidazole compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4302051A1 (de) 1993-01-26 1994-07-28 Thomae Gmbh Dr K 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2732967B1 (fr) 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
EP1115707B1 (en) 1998-09-25 2003-11-12 AstraZeneca AB Benzamide derivatives and ther use as cytokine inhibitors
PT1123287E (pt) 1998-10-23 2003-12-31 Dow Agrosciences Llc 1-(piridil substituido)-1,2,4-triazoles insecticidas
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
US20010044445A1 (en) * 1999-04-08 2001-11-22 Bamaung Nwe Y. Azole inhibitors of cytokine production
WO2003022820A1 (en) 2001-09-06 2003-03-20 Bristol-Myers Squibb Pharma Company. Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
DE60226756D1 (de) 2001-10-04 2008-07-03 Merck & Co Inc Heteroarylsubstituierte tetrazolmodulatoren des metabotropischen glutamatrezeptors-5
ES2367422T3 (es) 2001-10-09 2011-11-03 Amgen Inc. Derivados de imidazol como agentes antiinflamatorios.
AU2003209388A1 (en) 2002-01-29 2003-09-02 Merck And Co., Inc. Substituted imidazoles as cannabinoid receptor modulators
DE602004031759D1 (de) * 2003-12-03 2011-04-21 Boehringer Ingelheim Pharma 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion
US7485657B2 (en) * 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds

Similar Documents

Publication Publication Date Title
JP2006514940A5 (https=)
ES2327940T3 (es) 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas.
RU2757457C2 (ru) Пирролопиримидины в качестве потенциаторов мвтр
US7582630B2 (en) Pyradazine compounds as GSK-3 inhibitors
US7183306B2 (en) Pyrazole derivatives
US10308605B2 (en) Proton pump inhibitors
ES2566772T3 (es) Inhibidores de la quinasa c-fms
JP5659166B2 (ja) ピリダジノン化合物
US20090239845A1 (en) Pyrazole compounds as prostaglandin receptors ligands
KR101071438B1 (ko) 카나비노이드 수용체 길항제로서의피라졸로[1,5-a]피리미딘 화합물
CA2507184A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors
JP5379690B2 (ja) 5員複素環化合物
US20080153810A1 (en) Indazole derivatives useful as melanin concentrating receptor ligands
CN1333767A (zh) 作为消炎剂的芳香族杂环化合物
CN101243090A (zh) p38 MAP激酶抑制剂及使用它的方法
CN101084195A (zh) 作为5-ht2a血清素受体调节剂适用于治疗与其相关的病症的3-苯基-吡唑衍生物
CN1203589A (zh) 新的化合物
JP2007536231A5 (https=)
JP2007513167A5 (https=)
JP2005530730A5 (https=)
JP2006522784A (ja) 炎症疾患の治療でp38MAPキナーゼインヒビターとして使用の5‐アミノ‐2‐カルボニルチオフェン誘導体
JP2007537255A5 (https=)
CN104024250A (zh) 作为痕量胺相关受体(taar)的杂环衍生物
BG65369B1 (bg) Дифенилетерни съединения, приложими в терапията
WO1999025695A1 (en) 5-arylpyrazole compounds